---
title: "OmniAb names Amechi Nwachuku as COO"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292485162.md"
description: "OmniAb has appointed Amechi Nwachuku as Executive Vice President and Chief Operating Officer in a newly created role, effective immediately. Nwachuku will oversee strategy, operations, and commercial rollout for the company's xPloration platform. He previously served as Vice President of Global Commercial Genetic Sciences at Thermo Fisher and held senior roles at SCIEX within Danaher."
datetime: "2026-07-13T12:03:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292485162.md)
  - [en](https://longbridge.com/en/news/292485162.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292485162.md)
generator: "portal-rs"
---

# OmniAb names Amechi Nwachuku as COO

-   OmniAb appointed Amechi Nwachuku executive vice president, chief operating officer, effective today, in a newly created role. \* He will run strategy, operations, commercial rollout for xPloration, its high-throughput single B-cell screening platform. \* Nwachuku was vice president, global commercial genetic sciences at Thermo Fisher. \* Earlier roles include senior vice president, global commercial at SCIEX within Danaher. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OmniAb Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607130800BIZWIRE\_USPR\_\_\_\_\_20260713\_BW808637) on July 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [OABI.US](https://longbridge.com/en/quote/OABI.US.md)
- [TMO.US](https://longbridge.com/en/quote/TMO.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)
- [OABIW.US](https://longbridge.com/en/quote/OABIW.US.md)

## Related News & Research

- [OmniAb Raises 2026 Financial Guidance | OABI Stock News](https://longbridge.com/en/news/296088999.md)
- [Why Is Omniab Stock Rallying After Eli Lilly Deal?](https://longbridge.com/en/news/296113651.md)
- [Ultragenyx Wins FDA Approval for GENGLYCOS, Its First Gene Therapy](https://longbridge.com/en/news/296478943.md)
- [OmniAb (NASDAQ:OABI) Issues Quarterly Earnings Results, Beats Expectations By $0.07 EPS](https://longbridge.com/en/news/295310097.md)
- [Waters names Tina Wu head of Analytical Sciences division after Carpio resignation](https://longbridge.com/en/news/296623678.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**